MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-HP-11-0001874
Marvellon Pharmaceuticals Private Limited - pharma in Panchkula, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.96 Cr
▲ 12% YoY
Net profit · FY 2025
₹2.77 Lakh
Net margin 0.6%
EBITDA · FY 2025
₹52.63 Lakh
EBITDA margin 10.6%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹30 Lakh
Issued & subscribed
Open charges
₹1.7 Cr
Satisfied ₹80 Lakh
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
About Marvellon Pharmaceuticals Private Limited
Data last updated:
Marvellon Pharmaceuticals Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100HR2019PTC079580. Its GSTIN is 02AAGCV8845H1Z4 (Himachal Pradesh).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It was formerly known as Vvpb Pharmaceuticals Private Limited. It is led by directors Anil Kumar and Amit Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Panchkula, Haryana.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.96 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹2.77 Lakh (net margin 0.6%) and EBITDA of ₹52.63 Lakh (EBITDA margin 10.6%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years.
As per MCA filings, the company has open charges of ₹1.7 Cr and satisfied charges of ₹80 Lakh on record. Court records list 7 cases involving the company, including 1 filed by the company and 6 filed against it; 5 cases are pending.
Marvellon Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0001874). For more details, the company can be reached via its website marvellonpharma.com.
Company details
CIN U24100HR2019PTC079580
Registration Number 079580
Incorporation Date 04 April 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-HP-11-0001874
Key People
Anil Kumar Director Amit Kumar Director Recognitions & Rankings of Marvellon Pharmaceuticals
Contact details
Marvellon Pharmaceuticals Private Limited's registered office is in Panchkula, Haryana. Its website is marvellonpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNear Punjab National Bank Vill – Marranwala P.O – Nanakpur Tehsi, L – Kalka, Panchkula, Haryana, India – 134102
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Marvellon Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Marvellon Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Marvellon Pharmaceuticals is manufacturing. In detail, this covers wood and wood products, furniture, paper and paper products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C3 | Wood and wood products, furniture, paper and paper products |
To see the full business activity and turnover split of Marvellon Pharmaceuticals Private Limited, buy the company report.
Financials of Marvellon Pharmaceuticals Private Limited
FY 2024 filings availableMarvellon Pharmaceuticals Private Limited reported revenue of ₹4.96 Cr (up 12% YoY) for FY 2025.
Revenue · FY 2025
₹4.96 Cr ▲ 12%
Net profit · FY 2025
₹2.77 Lakh margin 0.6%
EBITDA · FY 2025
₹52.63 Lakh margin 10.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▲ 26%
3 years · compounded
▲ 34%
5 years · compounded
▲ 51%
Revenue has grown at a compounded annual rate (CAGR) of 2% over three years, including 12% growth in the latest year. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹52.63 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.77 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.6% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Marvellon Pharmaceuticals Private Limited, buy the company report.
Board of directors of Marvellon Pharmaceuticals Private Limited
Marvellon Pharmaceuticals has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar | Director | 27 Oct 2020 | 6 Years 0 Months | Current |
| Amit Kumar | Director | 27 Oct 2020 | 6 Years 0 Months | Current |
Auditor
Marvellon Pharmaceuticals Private Limited is audited by D A R & CO LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D A R & CO LLP | FY 2023 | 0029850N |
Shareholding
The shareholding of Marvellon Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Marvellon Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.7 Cr
Satisfied charges
₹80 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Jul 2022 | 100606477 | Canara Bank | ₹1.7 Cr | Open | |
| 13 Dec 2019 | 100322087 | Others | ₹80 Lakh | Satisfied |
To see the full charge records of Marvellon Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Marvellon Pharmaceuticals Private Limited has 7 court cases on record: 1 filed by Marvellon Pharmaceuticals, 6 filed against it. 5 cases are pending and 2 are disposed.
Total cases
7
Filed by the company
1
Filed against the company
6
Pending
5
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 6 | 5 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Solan, Himachal Pradesh | Court case (Drugs And Cosmetics Act) | Filed against the company by State of HP (Through Drugs Inspector) | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by an individual | Pending |
| District court, Solan, Himachal Pradesh | Civil miscellaneous application | Filed by the company against M/S Asiatic Pharmaceuticlas | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons warrant cases SW) | Filed against the company by State of Maharashtra Through Shri Rakesh M Edlawar Drugs Inspector | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons warrant cases SW) | Filed against the company by State of Maharasbtra Through Sunil Harishchandra Gawali Drugs Inspector | Pending |
To see the full case history of Marvellon Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Marvellon Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Marvellon Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAGCV8845H1Z4 | Himachal Pradesh | Active | 12 Sep 2019 |
To see the full GST registrations and return filing status of Marvellon Pharmaceuticals Private Limited, buy the company report.
Recent activity
Marvellon Pharmaceuticals Private Limited has 11 board changes on record since 2020: 2 appointments and 9 cessations. The latest: Amit Kumar ceased to be Additional Director on 10 Dec 2022.
AGM
Marvellon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Marvellon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Canara Bank of Rs. 169.60 Lakh registered on 13 Jul 2022 with Charge ID 100606477 was modified on 16 Aug 2023.
Ceased
Amit Kumar ceased to be Additional Director.
Ceased
Anil Kumar ceased to be Additional Director.
Charges
A charge with Canara Bank amounted to Rs. 169.60 Lakh with Charge ID 100606477 was registered on 13 Jul 2022.
Ceased
Amit Dhankar ceased to be Additional Director.
Ceased
Vikas Punia ceased to be Additional Director.
Ceased
Vijendra Kumar Bohre ceased to be Additional Director.
Charges
A charge registered on 13 Dec 2019 via Charge ID 100322087 with Others was fully satisfied on 16 Nov 2020.
Ceased
Ashwani Kumar ceased to be Director.
Ceased
Gopalakrishnam Venkatasubramanyam ceased to be Managing Director.
6 earlier events are in the company report.
Frequently asked questions
Marvellon Pharmaceuticals is an active private limited company based in Panchkula, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 April 2019 (7+ years old) and is registered under CIN U24100HR2019PTC079580.
Marvellon Pharmaceuticals has 2 current directors:
- Anil Kumar - Director
- Amit Kumar - Director
The latest financial statements of Marvellon Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Marvellon Pharmaceuticals is 02AAGCV8845H1Z4, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Marvellon Pharmaceuticals is U24100HR2019PTC079580. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Marvellon Pharmaceuticals has 7 court cases on record: 1 filed by the company and 6 filed against it. 5 are pending.
Marvellon Pharmaceuticals was incorporated on 04 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Amit Kumar ceased to be Additional Director on 10 Dec 2022. Anil Kumar ceased to be Additional Director on 10 Dec 2022. Amit Dhankar ceased to be Additional Director on 27 Jan 2022. Marvellon Pharmaceuticals has 11 board changes on record in total.
Yes, Marvellon Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HP-11-0001874).
Marvellon Pharmaceuticals can be reached through the website marvellonpharma.com. Its registered office is in Panchkula, Haryana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages